Abstract:5173 In vitro studies suggest that there is functional crosstalk between ERα and the IGF-1 signaling cascade, which includes potentiation of IGF-1 responses by ERα, and stimulation of ERα activity by IGF-1. To study the role of ERα in the effects of IGF-1 in vivo, we used the BK5.IGF-1 transgenic (Tg) mouse model in which human IGF-1 is expressed by keratin 5-positive mammary myoepithelial cells, and acts in a paracrine manner on the adjacent ductal epithelium. Previously, we found that mammary tumor incidence was significantly increased in Tg animals compared to wild-types (WT). To evaluate the mechanism by which paracrine IGF-1 affects susceptibility to carcinogenesis, mammary glands from WT and Tg pre-pubertal (4-5 wks old) and post-pubertal (8-13 wks old) mice were analyzed. In pre-pubertal glands, overexpression of IGF-1 induced a significant increase in phosphorylation of IGF-1R, IRS-1, Akt and mTOR, but not MAPK. Since the PI3K/Akt pathway is known to primarily phosphorylate serine 167 of ERα while the Ras/Raf/MAPK pathway phosphorylates serine 118, we then evaluated ERα phosphorylation using site-specific antibodies. Phosphorylation of serine 167, but not 118, was found to be elevated in pre-pubertal Tg glands, further indicating activation of the PI3K/Akt pathway. Cyclin D1 expression was also significantly higher in Tg pre-pubertal glands compared to glands from age-matched WTs. Conversely, in post-pubertal mice, IGF-1 overexpression resulted in increased phosphorylation of IGF-1R, MAPK, and mTOR, but not IRS-1 or Akt. Cyclin D1 expression was not increased in Tg post-pubertal glands either. These data indicate that IGF-1 stimulates signaling predominantly via the PI3K/Akt pathway in pre-pubertal mice, and the Ras/Raf/MAPK pathway in post-pubertal mice. Meanwhile, ERα expression level was comparable in glands from Tg and WT pre-pubertal mice, but significantly reduced in Tg post-pubertal glands compared to WTs. To further clarify whether ERα plays a role in the ′signaling pathway switch,′ protein extracts from glands from both age groups were immunoprecipitated with IRS-1 antibody, and then immunoblotted with ERα antibody. Results showed that ERα coprecipitated with IRS-1 in extracts from Tg pre-pubertal but not post-pubertal glands. In summary, our data showed that in pre-pubertal Tg mice, where ERα levels were high, IGF-1 induced the formation of the IRS-1/ERα complex, and stimulated activation of the PI3K/Akt pathway; while in post-pubertal Tg mice, where ERα levels were significantly reduced, the IRS-1/ERα complex was not formed, and IGF-1 signaling proceeded predominantly through the MAPK pathway. Therefore, these findings indicate that the level of ERα expression determines the signal transduction pathway activated by IGF-1, which in turn affects cyclin D1 expression and the proliferation response.

Interaction between insulin-like growth factors Ⅰ receptor and estrogen receptor induced by estradiol and insulin-like growth factors Ⅰ

Interaction Between Igf-Ir And Er Induced By E2 And Igf-I

Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1.

Igfbp-Rp1 Acts As A Potential Tumor Suppressor Via the Suppression of Erk Signaling Pathway in Endometrial Cancer Cells

Insulin-like Growth Factor-I Stimulates Estrogen Receptor Beta and Aromatase Expression Via PI3K/AKT-mediated Transcriptional Activation in Endometriosis

Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes

Igf-I Stimulates Er Beta And Aromatase Expression Via Igf1r/Pi3k/Akt-Mediated Transcriptional Activation In Endometriosis

Estrogen Upregulates the IGF-1 Signaling Pathway in Lung Cancer Through Estrogen Receptor-Β

Role of Suppressor Encoprotein PTEN in IGF-1 Induced Activation of ERK in Endometrial Carcinoma Cells

Regulatory Mechanism in Expression of IRS-1 and 2 by Estrogen and High Concentration of Insulin

IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis

Ginsenoside Rg1 Exerts Estrogen-Like Activities Via Ligand-Independent Activation of ERα Pathway

Regulation of IGFs Expression in Endometrial Carcinoma Cells by Estrogen and Progesterone

Estrogen Receptor Α-Mediated Signaling Inhibits Type I Interferon Response to Promote Breast Carcinogenesis

Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways

[Estradiol Stimulates Proliferation of Prostatic Smooth Muscle Cells Via Estrogen Receptor Alpha and IGF1].

Estrogen receptor α (ERα) regulates insulin-like growth factor-1 (IGF-1) action in mammary glands in vivo

Re-expression of Estrogen Receptor Alpha in Estrogen Receptor Alpha-Negative MCF-7 Cells Restores Both Estrogen and Insulin-Like Growth Factor-Mediated Signaling and Growth.

Estrogen Receptor Β1 Expression Patterns Have Different Effects on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors' Treatment Response in Epidermal Growth Factor Receptor Mutant Lung Adenocarcinoma.

Effect of Estrogen on PDZK1 Protein in Breast Cancer Cells

PARTIALY INHIBITION OF THE EFFECTS OF ESTRODIOL ON RETINAL ENDOTHELIAL CELL BY NGF SIGNALING BLOCKAGE